Industry Reports
Mundipharma and CellAct announce new deal for the worldwide development and commercialization of smart chemotherapy CAP7.1
The Mundipharma network of independent associated companies announced that it has acquired from CellAct the worldwide development, commercialization and manufacturing rights to CAP7.1. CAP7.1 is a novel pro-drug of anticancer agent etoposide which is metabolized into...
Industry Reports
IFM Therapeutics To Be Acquired by Bristol- Myers Squibb To Strengthen Oncology Pipeline Focus On Innate Immunity
Bristol-Myers Squibb Company and IFM Therapeutics announced that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of IFM Therapeutics, a venture-backed biotech company focused on developing therapies that...
Industry Reports
TraceLink Breaks New Record for Highest Quarterly Sales Bookings in Q2 2017
TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced financial and company results for the second quarter of 2017. ...
Industry Reports
TraceLink expands offering with ROC IT Solutions acquisition
TraceLink Inc., the world’s largest track and trace network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that it has acquired ROC IT Solutions, the leader in intelligent edge...
Industry Reports
Valeant Pharma Announces Sale Of Obagi Medical Products Business
Valeant Pharmaceuticals International, Inc announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P. Limited partners...
Industry Reports
Medicure Closes Acquisition of Additional Interests in Apicore
Medicure Inc , a leading Canadian specialty pharmaceutical company, is pleased to announce that it has closed the acquisition of additional interests in Apicore Inc. and Apicore LLC (together "Apicore") from Apicore's founding shareholders as previously announced on July...
Industry Reports
Imprimis Pharmaceuticals Sells Pennsylvania Facility and Sinus Assets
Imprimis Pharmaceuticals, Inc , an ophthalmology-focused pharmaceutical company, announced it has entered into an agreement to sell its Folcroft, Pennsylvania facility and sinus related assets for $450,000. Â The closing of this transaction is expected to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
